By all measures, the addition of nab-paclitaxel for the treatment of patients with advanced pancreatic cancer was superior to the survival for patients who received only…

The Food and Drug Administration’s recent approval for Celgene’s (NASDAQ: CELG ) Abraxane as a treatment for pancreatic cancer is good news for the patient community.…

A highly targeted cancer radiation therapy may offer a safe and effective treatment option for elderly pancreatic cancer patients unable to undergo surgery or combined chemotherapy…

In a large new study of older Americans, researchers find that people with the healthiest eating habits are about 15 percent less likely to develop pancreatic cancer than those with…

New research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine could aid efforts to diagnose and…

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular…

A new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of…

A University of Colorado Cancer study published this week in the journal Carcinogenesis shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose,…

A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation

A team from the Perelman…

Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage of those who survived…

A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic…

Those who smoke and drink heavily may develop pancreatic cancer at an earlier age than those who don’t, according to a study led by a University…

A new study finds significant associations between antibodies for multiple oral bacteria and the risk of pancreatic cancer, adding support for the emerging idea that the ostensibly distant medical conditions…

Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years…

Investigators at the University of Texas MD Anderson Cancer Center, Houston, have reported on a new approach to treating previously inoperable complex pancreatic adenocarcinoma…

By simply shining a tiny light within the small intestine, close to that organ’s junction with the pancreas, physicians at Mayo Clinic’s campus in Florida have been able…

Aggressive pancreatic tumours may be treatable with a new class of drugs, according to Cancer Research UK

Less than one in five people with this form of cancer are still…

Researchers at Dana-Farber Cancer Institute have shown that advanced pancreatic cancers in mice can’t survive without continued expression of a mutant oncogene that “rewires” key metabolic pathways to fuel…

The dietary supplement gamma-linoleic acid can inhibit the growth of a subset of pancreatic cancer cells and selectively promote cancer cell death in mice, a Mayo Clinic…

Pancreatic cancer kills more than 40,000 people every year, and among cancers it’s particularly insidious. For 80 percent of patients, the disease is already so advanced…

A minimally invasive procedure that uses electrical pulses to target cancer cells may help make surgery an option for unresectable, locally advanced pancreatic cancer patients, researchers said here.

In a…

Researchers at Queen Mary, University of London have identified a new protein that makes pancreatic cancer cells less ‘sticky’ and therefore less able to attach to and invade…

Scientists at Fred Hutchinson Cancer Research Center and the Translational Genomics Research Institute (TGen) have discovered a literal ‘break through’ in pancreatic cancer.

A unique…

Pancreas cancer tumors spread quickly and are notoriously resistant to treatment, making them among the deadliest of malignancies. Their resistance to chemotherapy stems in part from a unique biological barrier…

A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer’s development but in its continued growth, according to a new study from University of…